Premium
Phase II trial of nab‐paclitaxel in patients with relapsed or refractory multiple myeloma
Author(s) -
Jain Tania,
Dueck Amylou C.,
Kosiorek Heidi e.,
Ginos Brenda F.,
Mayo Angela,
Reeder Craig B.,
Chesi Marta,
Mikhael Joseph,
Keith Stewart A.,
Leif Bergsagel P.,
Fonseca Rafael
Publication year - 2016
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24548
Subject(s) - paclitaxel , bortezomib , medicine , carfilzomib , lenalidomide , tolerability , multiple myeloma , pharmacology , pomalidomide , oncology , chemotherapy , adverse effect
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom